GLPG
Galapagos - Strong buy PT $240 > $480We think Galapagos is undervalued at current levels. The price will be heading $240 soon.
Cup and Handle formation.
The RSI / MACD and volume showing signs of recovery from recent 60% correction.
First price target: $ 240
Second price target: $350 - $480 (2022/23)
Full year 2020 results:
18 Febuary 2021
Webcast 19 February 2021, 14.00 CET
Events:
January 27, 2021
Degroof Petercam Healthcare Conference
February 23, 2021
10th Annual SVB Leerink Global Healthcare Conference 2021
March 01, 2021
Raymond James virtual Institutional Investors Conference
March 01, 2021
Cowen 41st Annual Health Care Conference
March 02, 2021
Credit Suisse London 2021 Healthcare Conference
March 09, 2021
Barclays Global Healthcare Conference
May 05, 2021
Kempen’s Life Sciences Conference
May 11, 2021
BofA Global Research 2021 Health care conference
June 15, 2021
Citi 10th Annual European Healthcare Conference
September 08, 2021
Citi Global Biopharma Conference
September 22, 2021
Bernstein’s 18th Annual Strategic Decisions Conference (SDC)
November 16, 2021
Stifel 2021 Healthcare Conference
Galapagos - Monthly outlookWe are currently in the middle of the month and Christmas is coming. This is a quiet period and normally there will be little movement here. We can therefore conclude that the biggest moves of the month have now come to an end within a week. Assuming that the price closes around this value at the end of the month, we see a pretty good respectation around 200. This may mean that the price will first fall back to the 175 area and then, potentially, break through all time highs.
On the weekly timeframe we see that the 200 level is enormously respected. This is a strong signal that the price could fall back to the indicated 175. This does not necessarily mean that this must necessarily go there, but a correction towards that area would be very common. The moment the price lingers around 175 and creates a solid bottom, there is again a great chance of a price move up and certainly also the possibility of making a new all time high. The next publication is in February, which means that the biggest fundamental influences stay out until that time.
If you have GLPG in your portfolio you should not be surprised when the stock drops a little in the next months. That would be a healthy cycle of the market. In the short term it would therefore not be a very bad idea to sell GLPG relatively close to 200. On the medium / long-term price timeframe the 200 was your ideal target.
If you want to buy GLPG; I would wait a bit. It is not the most favorable price to get in. There are plenty of other stocks that are more attractive to buy.